Rezolute, Inc.
RZLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509261
No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Rezolute, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q4 2021
- Shares held
- 7.09M
- −444.0K (−5.9%) vs. Q4 2021
- Total value
- $24.0M
- −$12.0M (−33.4%) vs. Q4 2021
- New holders
- 4
- 7 more added
- Sold out
- 6
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RZLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 144 | $450.3M |
| Q1 2026 | 125 | $263.2M |
| Q4 2025 | 122 | $213.4M |
| Q3 2025 | 116 | $817.1M |
| Q2 2025 | 92 | $347.5M |
| Q1 2025 | 77 | $130.6M |
| Q4 2024 | 71 | $211.7M |
| Q3 2024 | 59 | $186.9M |
| Q2 2024 | 52 | $170.0M |
| Q1 2024 | 33 | $69.0M |
| Q4 2023 | 32 | $28.7M |
| Q3 2023 | 30 | $31.5M |
| Q2 2023 | 29 | $48.0M |
| Q1 2023 | 32 | $46.5M |
| Q4 2022 | 34 | $50.6M |
| Q3 2022 | 33 | $67.0M |
| Q2 2022 | 35 | $79.2M |
| Q1 2022 | 21 | $24.0M |
| Q4 2021 | 23 | $36.0M |
| Q3 2021 | 14 | $17.6M |
| Q2 2021 | 12 | $31.6M |
| Q1 2021 | 11 | $17.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Rezolute, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 72 | $0 | 0.00% | +1+1.4% | Added |
| Morgan Stanley | 21 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 610 | $2.00K | 0.00% | +610 | New |
| The PNC Financial Services Group, Inc. | 750 | $3.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,491 | $15.0K | 0.00% | +183+4.2% | Added |
| Provence Wealth Management Group | 20,000 | $68.0K | 0.08% | +20,000 | New |
| State Street Corp | 20,300 | $69.0K | 0.00% | +20,300 | New |
| BlackRock Inc. | 21,528 | $72.0K | 0.00% | +1,945+9.9% | Added |
| Boothbay Fund Management, LLC | 24,000 | $81.0K | 0.00% | −12,922−35.0% | Reduced |
| Northern Trust Corp | 51,516 | $174.0K | 0.00% | −777−1.5% | Reduced |
| J. Goldman & Co LP | 54,000 | $183.0K | 0.01% | −148,500−73.3% | Reduced |
| Geode Capital Management, LLC | 68,989 | $233.0K | 0.00% | +68,989 | New |
| Worth Venture Partners, LLC | 104,709 | $354.0K | 0.17% | +43,991+72.5% | Added |
| BVF Inc | 190,815 | $645.0K | 0.03% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 300,000 | $1.01M | 0.94% | 00.0% | Unchanged |
| Citadel Advisors LLC | 327,953 | $1.11M | 0.00% | +19,666+6.4% | Added |
| Vanguard Group Inc | 343,739 | $1.16M | 0.00% | +10,500+3.2% | Added |
| AIGH Capital Management LLC | 420,913 | $1.42M | 0.52% | +155,732+58.7% | Added |
| Stonepine Capital Management, LLC | 748,702 | $2.53M | 1.05% | −59,703−7.4% | Reduced |
| Caxton Corp | 1,193,473 | $4.03M | 5.02% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,189,222 | $10.8M | 0.02% | 00.0% | Unchanged |
| Altium Capital Management LP | 0 | $0 | 0.00% | −230,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −115,758−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −104,053−100.0% | Sold out |
| Sender Co & Partners, Inc. | 0 | $0 | 0.00% | −81,849−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −20,571−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −11,780−100.0% | Sold out |